Literature DB >> 17198452

Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features.

Mohammad-Reza Ghavam-Nasiri1, Ezzatollah Rezaei, Kamran Ghafarzadegan, Mehdi Seilanian-Toosi, Hamideh Malekifard.   

Abstract

BACKGROUND: The p53 gene mutation is closely related to carcinogenesis in most malignant diseases. The main function of wild p53 protein is to maintain the integrity of genes by detecting mutations and preventing the division of cells with damaged DNA. The mutated form of p53 protein is overexpressed due to an extended half-life and can be easily detected by immunohistochemistry.
OBJECTIVE: To estimate the frequency of p53 protein overexpression in colorectal carcinoma and its correlation with some clinicopathologic variables.
METHODS: One hundred paraffin-preserved colorectal carcinoma samples were collected randomly from patients undergoing tumor resection from April 1995 through April 2001 in Omid Hospital, affiliated to Mashhad University of Medical Sciences, Mashhad, Iran. The overexpression of p53 protein was studied using a monoclonal antibody (clone DO-7; Dako). The number of cells stained were classified semiquantitatively as (-): <5% positive cells, (+): 5 - 25% positive cells, (++): 25 - 75% positive cells, and (+++): >75% positive cells. Clinicopathologic data including gender, age, tumor location, histologic type, and stage (Astler-Coller) were collected from the files maintained at the Department of Pathology. The correlation between p53 protein overexpression and each variable was evaluated using Chi-square analysis.
RESULTS: p53 staining was positive in 59 of 100 specimens. Out of these 100 specimens, 16 were weekly (+), 16 moderately (++), and 27 intensely (+++) positive for p53 protein over-expression. There was no significant correlation between p53 staining and gender (P = 0.34), age (< 40 vs. > or = 40 yr; P = 0.74), site of tumor (right vs. left colon and rectum; P = 0.26), pathologic type (mucinous vs. nonmucinous; P = 0.63), and stage of the disease (P = 0.12).
CONCLUSION: Considering the p53 protein overexpression in a relatively high percentage of patients, it seems that p53 mutation plays an important role in development of colorectal carcinoma. There was no significant association between p53 protein expression and some common clinicopathologic variables such as age, gender, site of tumor, pathologic type, and stage of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198452     DOI: 07101/AIM.0010

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  13 in total

1.  Correlation of p53 Overexpression with the Clinicopathological Prognostic Factors in Colorectal Adenocarcinoma.

Authors:  Vijaya Mysorekar; Adithi Raj; Smitha Shetty
Journal:  J Clin Diagn Res       Date:  2016-12-01

2.  Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9.

Authors:  Jacqueline L Y Chee; Suzan Saidin; David P Lane; Sai Mun Leong; Jacqueline E Noll; Paul M Neilsen; Yi Ting Phua; Hani Gabra; Tit Meng Lim
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Vanillin differentially affects azoxymethane-injected rat colon carcinogenesis and gene expression.

Authors:  Ket Li Ho; Pei Pei Chong; Latifah Saiful Yazan; Maznah Ismail
Journal:  J Med Food       Date:  2012-12-10       Impact factor: 2.786

4.  Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression.

Authors:  Eva S Schernhammer; Shuji Ogino; Charles S Fuchs
Journal:  Gastroenterology       Date:  2008-06-12       Impact factor: 22.682

5.  Hedgehog Gli3 activator signal augments tumorigenicity of colorectal cancer via upregulation of adherence-related genes.

Authors:  Hironori Iwasaki; Kenji Nakano; Kentaro Shinkai; Yumi Kunisawa; Minako Hirahashi; Yoshinao Oda; Hideya Onishi; Mitsuo Katano
Journal:  Cancer Sci       Date:  2013-01-10       Impact factor: 6.716

6.  The roles of p53 and XPO1 on colorectal cancer progression in Yemeni patients.

Authors:  Mohammed Aladhraei; Eman Al-Salami; Naravat Poungvarin; Prasit Suwannalert
Journal:  J Gastrointest Oncol       Date:  2019-06

Review 7.  Colorectal cancer in iran: molecular epidemiology and screening strategies.

Authors:  Roya Dolatkhah; Mohammad Hossein Somi; Mortaza Jabbarpour Bonyadi; Iraj Asvadi Kermani; Faris Farassati; Saeed Dastgiri
Journal:  J Cancer Epidemiol       Date:  2015-01-15

8.  Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.

Authors:  Xian Hua Gao; Guan Yu Yu; Hai Feng Gong; Lian Jie Liu; Yi Xu; Li Qiang Hao; Peng Liu; Zhi Hong Liu; Chen Guang Bai; Wei Zhang
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

9.  Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma.

Authors:  Jing Han; Xue Zhang; Yang Yang; Li Feng; Gui-Ying Wang; Nan Zhang
Journal:  Biomed Res Int       Date:  2020-01-21       Impact factor: 3.411

10.  Identification of the effects of acid-resistant Lactobacillus casei metallopeptidase gene under colon-specific promoter on the colorectal and breast cancer cell lines.

Authors:  Narges Dadfarma; Jamileh Nowroozi; Bahram Kazemi; Mojgan Bandehpour
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.